JPWO2020167996A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020167996A5
JPWO2020167996A5 JP2021546891A JP2021546891A JPWO2020167996A5 JP WO2020167996 A5 JPWO2020167996 A5 JP WO2020167996A5 JP 2021546891 A JP2021546891 A JP 2021546891A JP 2021546891 A JP2021546891 A JP 2021546891A JP WO2020167996 A5 JPWO2020167996 A5 JP WO2020167996A5
Authority
JP
Japan
Prior art keywords
gene therapy
therapy vector
raav gene
raav
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021546891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520232A (ja
JP2022520232A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017987 external-priority patent/WO2020167996A1/en
Publication of JP2022520232A publication Critical patent/JP2022520232A/ja
Publication of JP2022520232A5 publication Critical patent/JP2022520232A5/ja
Publication of JPWO2020167996A5 publication Critical patent/JPWO2020167996A5/ja
Priority to JP2025007633A priority Critical patent/JP2025063228A/ja
Pending legal-status Critical Current

Links

JP2021546891A 2019-02-12 2020-02-12 ダノン病の治療のための遺伝子療法ベクター Pending JP2022520232A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025007633A JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962804521P 2019-02-12 2019-02-12
US62/804,521 2019-02-12
US201962934928P 2019-11-13 2019-11-13
US62/934,928 2019-11-13
PCT/US2020/017987 WO2020167996A1 (en) 2019-02-12 2020-02-12 Gene therapy vectors for treatment of danon disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025007633A Division JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Publications (3)

Publication Number Publication Date
JP2022520232A JP2022520232A (ja) 2022-03-29
JP2022520232A5 JP2022520232A5 (https=) 2023-02-21
JPWO2020167996A5 true JPWO2020167996A5 (https=) 2023-02-21

Family

ID=72043957

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021546891A Pending JP2022520232A (ja) 2019-02-12 2020-02-12 ダノン病の治療のための遺伝子療法ベクター
JP2025007633A Pending JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025007633A Pending JP2025063228A (ja) 2019-02-12 2025-01-20 ダノン病の治療のための遺伝子療法ベクター

Country Status (12)

Country Link
US (1) US20220143215A1 (https=)
EP (1) EP3924371A4 (https=)
JP (2) JP2022520232A (https=)
KR (1) KR20210125999A (https=)
CN (2) CN113508130A (https=)
AU (3) AU2020221842A1 (https=)
BR (1) BR112021015751A2 (https=)
CA (1) CA3128514A1 (https=)
IL (1) IL285238A (https=)
MX (1) MX2021009696A (https=)
SG (1) SG11202107744SA (https=)
WO (1) WO2020167996A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3021572A1 (en) 2016-04-20 2017-10-26 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Compositions and methods for enhanced gene expression of pklr
EP3697452A4 (en) 2017-10-16 2021-11-24 Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS
BR112020020841A2 (pt) 2018-04-11 2021-01-19 Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus Composições e métodos para transplante de célulastronco
CA3096293A1 (en) 2018-04-27 2019-10-31 Rocket Pharmaceuticals, Ltd. Gene therapy for cns degeneration
WO2020014523A1 (en) * 2018-07-12 2020-01-16 Rocket Pharmaceuticals, Ltd. Gene therapy vectors for treatment of danon disease
JP2023538519A (ja) 2020-08-07 2023-09-08 スペースクラフト セブン リミテッド ライアビリティ カンパニー Aavベクターを使用したプラコフィリン-2(pkp2)遺伝子治療
CA3201247A1 (en) * 2020-12-07 2022-06-16 Gaurav Shah Treatment of danon disease
CN114874990A (zh) * 2021-02-05 2022-08-09 中国科学院苏州纳米技术与纳米仿生研究所 一种功能化外泌体及其制备方法和应用
JP7564368B2 (ja) 2021-09-23 2024-10-08 エルジー エナジー ソリューション リミテッド 高耐熱性コネクター及びこれを含むバッテリーモジュール、バッテリーパック、自動車
CN114457112A (zh) * 2022-02-07 2022-05-10 苏州市立医院 一种特异性神经靶向mr分子探针及其制备方法和应用
CN115975051B (zh) * 2022-11-17 2025-09-12 东南大学 靶向外泌体及制备方法、应用、药物和药物递送系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985553B2 (en) * 2001-10-29 2011-07-26 Nathaniel Heintz Method for isolating cell type-specific mRNAs
US9217155B2 (en) * 2008-05-28 2015-12-22 University Of Massachusetts Isolation of novel AAV'S and uses thereof
US9434928B2 (en) * 2011-11-23 2016-09-06 Nationwide Children's Hospital, Inc. Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
AU2013221212B2 (en) * 2012-02-17 2018-08-09 The Children's Hospital Of Philadelphia AAV vector compositions and methods for gene transfer to cells, organs and tissues
DK3405215T3 (da) * 2016-01-19 2022-09-19 Univ California Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser
WO2017136536A1 (en) * 2016-02-02 2017-08-10 University Of Massachusetts Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
US11713468B2 (en) * 2017-08-02 2023-08-01 Dna Twopointo Inc. DNA vectors and elements for sustained gene expression in eukaryotic cells
WO2020014523A1 (en) * 2018-07-12 2020-01-16 Rocket Pharmaceuticals, Ltd. Gene therapy vectors for treatment of danon disease
EP3833745A1 (en) * 2018-08-10 2021-06-16 REGENXBIO Inc. Scalable method for recombinant aav production

Similar Documents

Publication Publication Date Title
AU2023201237B2 (en) Gene therapy vectors for treatment of Danon Disease
JP2021531752A5 (https=)
JP7654562B2 (ja) 線維芽細胞増殖因子23関連低リン血症性疾患の遺伝子療法
JPWO2020014523A5 (https=)
KR20230129431A (ko) 다농병의 치료
JPWO2020167996A5 (https=)
US20250041452A1 (en) Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector
KR20240118855A (ko) 바이러스 벡터로 bag-3 관련 심근병증을 치료하는 방법 및 조성물
JP2024509792A (ja) ファブリー病の治療のための組成物及び方法
CN115885043A (zh) 用于dwarf开放阅读框的腺相关病毒载体
KR20230029624A (ko) 유전자 치료를 위한 글루코스-6-포스파타제(G6Pase-a)를 코딩하는 벡터
CA3240197A1 (en) Compositions comprising kozak sequences selected for enhanced expression
RU2024118293A (ru) Векторы для генной терапии для лечения болезни данона
RU2822925C2 (ru) Векторы для генной терапии для лечения болезни данона
RU2021121516A (ru) Векторы для генной терапии для лечения болезни данона
WO2025253097A1 (en) Proteins with cardiopreservation activity
WO2025096910A1 (en) Cpg-free codon-optimized human microdystrophin for duchenne muscular dystrophy gene therapy
RU2023129510A (ru) Геннотерапевтические векторы для лечения болезни данона
RU2021103332A (ru) Геннотерапевтические векторы для лечения болезни данона